Pharma Focus Europe
ThermoFisher Scientific - Go beyond the catalog

Techno Trends

Worldwide advancements and breakthroughs in pharmaceutical products and technology are thoroughly covered by Techno Trends. You may stay up to date with all the most recent pharmaceutical developments (product news and technological trends) taking place throughout the world.

Santhera's AGAMREE® (Vamorolone) Granted First-of-Its-Kind Approval for Duchenne Muscular Dystrophy in the UK

Santhera Pharmaceuticals has recently announced the approval of AGAMREE® in the United Kingdom for the treatment of Duchenne muscular dystrophy in patients aged 4 and above, irrespective of their underlying mutation...

Coherus Novel UDENYCA ONBODY™ System Approved by FDA for pegfilgrastim-cbqv

Coherus BioSciences, a biopharmaceutical company in the commercial stage, has received approval from the U.S. Food and Drug Administration for its UDENYCA ONBODY. This is an on-body injector presentation of UDENYCA...

Evaxion to Develop Novel Personalized Cancer Vaccines Using AI-Unearthed Targets

Evaxion Biotech, a pioneering clinical-stage TechBio company, specializes in developing AI-Immunology™ powered vaccines. Recently, the company announced an enhanced dedication to crafting tailored cancer vaccines...

Geneseeq receives FDA Breakthrough Designation for Novel CanScan™ Multi-cancer Detection Solution

Geneseeq recently announced that its multi-cancer early detection solution, CanScan™, has received Breakthrough Device Designation from the US Food and Drug Administration...

Bristol Myers Squibb's Abecma® Approved as First CAR T Therapy for Earlier Treatment in Japan for Relapsed or Refractory Multiple Myeloma

Bristol-Myers Squibb has recently obtained regulatory approval for an expanded indication of Abecma® , a chimeric antigen receptor T cell therapy targeting B-cell maturation antigen...

UK MHRA Approves Novel CASGEVY™, the First CRISPR/Cas9 Gene-Editing Therapy

The UK Medicines and Healthcare products Regulatory Agency (MHRA) recently granted approval for CASGEVY™, marking a groundbreaking development as the first-ever therapy utilizing CRISPR/Cas9 gene-editing technology to treat sickle cell disease...

Abbisko Therapeutics Breakthrough CSF-1R Inhibitor, Pimicotinib (ABSK021), Receives Fast Track Designation from the U.S. FDA

Abbisko Therapeutics has recently disclosed that its CSF-1R inhibitor, pimicotinib (ABSK021), has been granted fast track designation by the U.S. Food and Drug Administration...

Bristol Myers Squibb's LPA1 Antagonist Granted FDA Breakthrough Designation for Progressive Pulmonary Fibrosis

Bristol Myers Squibb recently disclosed that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for BMS-986278, an oral antagonist targeting lysophosphatidic acid...

WuXi Biologics Achieves 6 g/L/day Novel Productivity in Pilot-Scale Continuous Process

WuXi Biologics, a leading Contract Research, Development, and Manufacturing Organization, recently achieved a significant milestone in end-to-end Drug Substance...

Cessation Therapeutics Novel CSX-1004 Receives FDA Fast Track Designation for Preventing Fentanyl Overdose

Cessation Therapeutics, a clinical-stage biotechnology company focused on advancing biologics targeting substances of abuse, announced today that the U.S. Food and Drug Administration...

Latest Issue
Get instant
access to our latest e-book
Lab Indonesia 2024Sartorius Lab Balance CleaningWorld Vaccine Congress Europe 2024World Orphan Drug Congress 2024Advanced Therapies 2024Equinix accelerated medical research...World Vaccine Congress Washington 2024EUROPEAN PHARMA OUTSOURCING SUMMIT 2024Pharma 2024